magAssist Recognized as "Rising Star" in CIC Insight Consulting's 4th "Top Growth Companies" List

Recently, the results of the 4th "Top Growth Companies" List organized by CIC Insight Consulting were officially announced. magAssist was recognized with the "Rising Star" award in the Advanced Medical Devices category, standing out among hundreds of participating companies.

This recognition reflects the company's continued efforts in life support technology innovation, clinical application capabilities, and industry contribution, and indicates acknowledgment from both industry stakeholders and the investment community.

——CIC Insight Consulting——

4th "Top Growth Companies"List

As a widely referenced benchmark in emerging industries and venture investment, the "Top Growth Companies" List evaluates high-potential enterprises across four key dimensions: technological advancement, industry impact, market growth potential, and sustainability.

Following multiple rounds of screening, expert review, and joint recommendations from investment institutions, the list identifies companies with strong development potential and the ability to contribute to industry innovation. The 2025 edition places particular focus on sectors such as medical devices and life sciences.

magAssist's inclusion reflects recognition of its ongoing innovation efforts and its role in advancing domestically developed life support technologies.

Innovation in Mechanical Circulatory Support

As a company focused on the field of mechanical circulatory support (MCS), magAssist continues to develop technologies across R&D, manufacturing, and clinical application.

Its product portfolio includes:

• MoyoAssist® Extracorporeal VAD 

• BreathMo® ECMO System【1】 

• NyokAssist® Percutaneous VAD【1】 

These products support multiple clinical scenarios and reflect the company's transition from single-product innovation toward a platform-based development approach.

Technological innovation remains central to magAssist's development strategy. The company focuses on key areas such as mechatronics integration and magnetically levitated control systems, with more than 400 patent applications to date.

In clinical settings, magAssist's technologies have been applied in scenarios including severe heart failure and complex cardiovascular procedures, providing circulatory support based on clinical requirements. Related clinical findings have been shared within the professional community.

Looking Ahead

The "Rising Star" recognition reflects continued progress in both innovation and clinical application. magAssist will continue to focus on advancing life support technologies, strengthening product development, and supporting broader clinical accessibility.

【1】This product information is intended for research and academic exchange only. These products have not received approval from the National Medical Products Administration (NMPA) and are not commercially available in any country or region.